Mangoceuticals, Inc. (MGRX)
Track the next or latest earnings date for Mangoceuticals, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
www.stocktitan.net · 5 days ago
Mangoceuticals sells 850,000 restricted common shares at $0.32 each to an accredited investor, raising $272,000 in a Regulation D private placement with one-year piggyback registration rights.
Down 35%, Is MercadoLibre Stock a Better Buy than SpaceX and the "Magnificent Seven" Stocks in July?finance.yahoo.com · 2 days ago
Is it a better buy than SpaceX and all of the Magnificent Seven stocks? When viewed in the context of how much it could grow your money over time, I think it is. And since the company plans to report second-quarter earnings Aug.
MercadoLibre Stock Has Been Left For Dead. Here's Why Investors Should Consider Buying More.finance.yahoo.com · 2 days ago
The Latin American commerce giant is facing margin pressure, but this is simply due to its long-term thinking.
Mangoceuticals Raises Capital via Private Equity Placement - TipRanks.comwww.tipranks.com · 5 days ago
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. The latest update is out from Mangoceuticals, Inc. ( (MGRX) ).
MRX Stock Price Quote | Morningstarmorningstar.com · 3 weeks ago
See the latest Marex Group PLC stock price (MRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: N/A
Revenue estimate: N/A
Market cap: $2.64M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Mar 19, 2026 | 2025-12-31 | Time not specified | N/A | N/A |